Randomized, prospective, double-masked, vehicle-controlled study to evaluate the safety and efficacy of topical Nexagon® in subjects with ocular surface chemical burns.
Phase 2, randomized, prospective, double-masked, vehicle-controlled, dose-ranging study to evaluate the efficacy and safety of Nexagon® in subjects with persistent corneal epithelial defects (PED) after either corneal transplant surgery or corneal epithelial debridement during diabetic vitrectomy surgery.